Neural Therapeutics Inc.
NURL
CNSX
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 75.30K | 37.60K | 116.40K | 38.10K | 67.30K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 83.90K | 73.60K | 152.10K | 73.40K | 129.50K |
| Operating Income | -83.90K | -73.60K | -152.10K | -73.40K | -129.50K |
| Income Before Tax | -81.50K | -73.70K | -152.70K | -90.40K | -130.70K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -81.50K | -73.70K | -152.70K | -90.40K | -130.70K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -81.50K | -73.70K | -152.70K | -90.40K | -130.70K |
| EBIT | -83.90K | -73.60K | -152.10K | -73.40K | -129.50K |
| EBITDA | -- | -- | -- | -- | -- |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 66.53M | 65.77M | 65.99M | 65.77M | 54.07M |
| Average Diluted Shares Outstanding | 66.53M | 65.77M | 65.99M | 65.77M | 54.07M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |